Clinical Trial Update: The K-Map Study, Global Prevalence of KC

View source ↗

Summary

The K-Map Study is currently recruiting at University Hospital, Geneva to investigate the global prevalence of keratoconus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Snippet

Sponsor: University Hospital, Geneva | Conditions: Keratoconus | Status: RECRUITING